HTATSF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.108600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.469800E-01
Normal-vs-Stage2
7.774000E-01
Normal-vs-Stage3
7.594000E-01
Normal-vs-Stage4
2.807000E-01
Stage1-vs-Stage2
6.880300E-02
Stage1-vs-Stage3
1.615590E-01
Stage1-vs-Stage4
5.394200E-01
Stage2-vs-Stage3
4.835000E-01
Stage2-vs-Stage4
5.030800E-01
Stage3-vs-Stage4
2.773600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.924800E-01
Normal-vs-AfricanAmerican
4.692800E-01
Normal-vs-Asian
7.155800E-01
Caucasian-vs-AfricanAmerican
7.785200E-01
Caucasian-vs-Asian
6.170400E-02
AfricanAmerican-vs-Asian
2.313400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.345400E-01
Normal-vs-Female
2.211000E-01
Male-vs-Female
8.556800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.472400E-01
Normal-vs-Age(41-60Yrs)
6.041600E-02
Normal-vs-Age(61-80Yrs)
8.002400E-01
Normal-vs-Age(81-100Yrs)
9.826600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.868000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.152010E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.052000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.080010E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.480300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.783200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.354600E-01
Normal-vs-Daily Drinker
9.070800E-01
Normal-vs-Weekly Drinker
6.453400E-01
Normal-vs-Occasional Drinker
3.164600E-01
Normal-vs-Social Drinker
2.143800E-01
Non Drinker-vs-Daily Drinker
7.189600E-01
Non Drinker-vs-Weekly Drinker
2.562600E-01
Non Drinker-vs-Occasional Drinker
2.129400E-01
Non Drinker-vs-Social Drinker
2.661400E-01
Daily Drinker-vs-Weekly Drinker
3.508000E-01
Daily Drinker-vs-Occasional Drinker
5.376000E-02
Daily Drinker-vs-Social Drinker
2.291000E-01
Weekly Drinker-vs-Occasional Drinker
1.515990E-02
Weekly Drinker-vs-Social Drinker
1.676960E-01
Occasional Drinker-vs-Social Drinker
4.503200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.278000E-01
Normal-vs-Grade 2
9.198400E-02
Normal-vs-Grade 3
7.570100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.022200E-01
Grade 1-vs-Grade 3
2.804600E-01
Grade 1-vs-Grade 4
4.278000E-01
Grade 2-vs-Grade 3
4.834400E-01
Grade 2-vs-Grade 4
9.198400E-02
Grade 3-vs-Grade 4
7.570100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.257400E-01
Normal-vs-NonDiabetic
7.161800E-01
Diabetic-vs-NonDiabetic
3.599200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.504800E-01
Normal-vs-NoPancreatitis
7.302800E-01
Pancreatitis-vs-NoPancreatitis
3.961000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.984100E-02
Normal-vs-N1
7.904200E-01
N0-vs-N1
9.335500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.538800E-01
Normal-vs-TP53-NonMutant
4.080300E-02
TP53-Mutant-vs-TP53-NonMutant
1.690970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
